Chromosomal Microarray Interpretation
Speaker:
Karen Tsuchiya, M.D.
Contact Hours:
1.0
Date:
October 12, 2025 - October 31, 2027
Description:
This presentation gives background information on Chromosomal Microarray (CMA) testing, discusses copy number variances, benign or pathogenetic CNVs, and uses examples to illustrate discrepancies among CNV reports from lab to lab.
Learning Objectives:
- Describe the principles and clinical applications of Chromosomal Microarray (CMA) testing, including its role in detecting copy number variations (CNVs).
- Differentiate between benign and pathogenic CNVs, and explain the criteria used to interpret their clinical significance.
- Identify factors that contribute to discrepancies in CNV reporting among laboratories, using case examples to illustrate interpretive challenges.